Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis-Reference-Cited by-同舟云学术

Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis

Published:2000 Issue: Volume: Page:361-373
ISSN:
Container-title:Advances in Research on Neurodegeneration
language:
Short-container-title:

Author:

Martin R.,Bielekova B.,Gran B.,McFarland H. F.

Publisher

Springer Vienna

Link

http://link.springer.com/content/pdf/10.1007/978-3-7091-6301-6_26.pdf

Reference103 articles.

1. Adelmann M, Wood J, et al (1995) The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63: 17-27

2. Amor S, Baker D, et al (1993) Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. J Immunol 150: 5666-5672

3. Amor S, Groome N, et al (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349-4356

4. Ando DG, Clayton J, et al (1989) Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 124: 132-143

5. Baker D, Rosenwasser OA, et al (1995) Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol 155: 4046-4051

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure;Frontiers in Neurology;2022-03-31

2. Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?;Frontiers in Neurology;2020-12-08

3. Safety of multiple sclerosis treatment in the long term in relation to teriflunomide and alemtuzumab;Klinická farmakologie a farmacie;2019-10-28

4. TYSABRI - new management of risk factors;Neurologie pro praxi;2017-07-01